公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2019 | Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection | TUNG-HUNG SU ; CHUN-JEN LIU ; TAI-CHUNG TSENG ; Chou S.-W; CHEN-HUA LIU ; HUNG-CHIH YANG ; SHANG-JU WU ; PEI-JER CHEN ; DING-SHINN CHEN ; CHI-LING CHEN ; JIA-HORNG KAO | Alimentary Pharmacology and Therapeutics | 10 | 9 | |
2007 | Early viral kinetics during treatment of chronic hepatitis C virus infection with pegylated interferon alpha plus ribavirin in Taiwan | Hsu C.-S.; CHUN-JEN LIU ; Lai M.-Y.; PEI-JER CHEN ; JIA-HORNG KAO ; DING-SHINN CHEN | Intervirology | 17 | 16 | |
2010 | Eastern asian expert panel opinion: Designing clinical trials of molecular targeted therapy for hepatocellular carcinoma | Yeo W.; PEI-JER CHEN ; Furuse J.; Han K.-H.; CHIUN HSU ; Lim H.-Y.; Moon H.; Qin S.; Yeoh E.-M.; Ye S.-L. | BMC Cancer | 4 | 4 | |
2007 | Ectopic liver with hepatocellular carcinoma in the peritoneum. | KAO-LANG LIU ; MING-CHIH HO ; PEI-JER CHEN | AJR. American journal of roentgenology | 6 | 7 | |
2011 | Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy | TAI-CHUNG TSENG ; Yu M.-L.; CHUN-JEN LIU ; Lin C.-L.; Huang Y.-W.; Hsu C.-S.; CHEN-HUA LIU ; Kuo S.F.-T.; Pan C.J.-H.; Yang S.-S.; Su C.-W.; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Antiviral Therapy | 76 | 70 | |
2013 | Effect of Parenteral Selenium Supplementation in Critically Ill Patients: A Systematic Review and Meta-Analysis | Huang T.-S.; Shyu Y.-C.; Chen H.-Y.; Lin L.-M.; Lo C.-Y.; Yuan S.-S.; PEI-JER CHEN | PLoS ONE | 96 | 97 | |
2011 | Effects of hepatitis B virus precore and basal core promoter mutations on the expression of viral antigens: Genotype B vs C | CHUN-JEN LIU ; Cheng H.-R.; Chen C.-L.; Chen T.-C.; TAI-CHUNG TSENG ; Wang Z.-L.; PEI-JER CHEN ; CHEN-HUA LIU ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Viral Hepatitis | 20 | 19 | |
2019 | Efficacy and safety of 12 weeks of daclatasvir, asunaprevir plus ribavirin for HCV genotype-1b infection without NS5A resistance-associated substitutions | Yu M.-L.; Hung C.-H.; Huang Y.-H.; Peng C.-Y.; Lin C.-Y.; Cheng P.-N.; Chien R.-N.; SHIH-JER HSU ; CHEN-HUA LIU ; Huang C.-F.; Su C.-W.; Huang J.-F.; CHUN-JEN LIU ; JIA-HORNG KAO ; Chuang W.-L.; PEI-JER CHEN ; DING-SHINN CHEN | Journal of the Formosan Medical Association | 10 | 8 | |
2010 | Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma | CHIH-HUNG HSU ; Yang T.-S.; CHIUN HSU ; Toh H.C.; Epstein R.J.; Hsiao L.-T.; PEI-JER CHEN ; ZHONG-ZHE LIN ; Chao T.-Y.; ANN-LII CHENG | British Journal of Cancer | 114 | 112 | |
2000 | Efficacy of consensus interferon in the treatment of chronic hepatitis C | JIA-HORNG KAO ; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN | Journal of Gastroenterology and Hepatology (Australia) | 12 | 7 | |
2018 | Efficacy of Ledipasvir and Sofosbuvir Treatment of HCV Infection in Patients Coinfected With HBV | CHUN-JEN LIU ; Chuang W.-L.; Sheen I.-S.; Wang H.-Y.; Chen C.-Y.; Tseng K.-C.; Chang T.-T.; Massetto B.; Yang J.C.; Yun C.; Knox S.J.; Osinusi A.; Camus G.; Jiang D.; Brainard D.M.; McHutchison J.G.; Hu T.-H.; Hsu Y.-C.; Lo G.-H.; Chu C.-J.; Chen J.-J.; Peng C.-Y.; Chien R.-N.; PEI-JER CHEN | Gastroenterology | 95 | 82 | |
2020 | Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis | CHEN-HUA LIU ; Peng C.-Y.; YU-JEN FANG ; Kao W.-Y.; Yang S.-S.; Lin C.-K.; Lai H.-C.; Su W.-P.; Fang S.-U.; Chang C.-C.; TUNG-HUNG SU ; CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Scientific Reports | 8 | 6 | |
2005 | Electrical detection of DNA hybridization with multilayer gold nanoparticles between nanogap electrodes | Tsai C.-Y.; Tsai Y.-H.; Pun C.-C.; Chan B.; Luh T.-Y.; Chen C.-C.; Ko F.-H.; PEI-JER CHEN ; Chen P.-H. | Microsystem Technologies | 22 | 21 | |
2015 | Elevated p53 promotes the processing of miR-18a to decrease estrogen receptor-α in female hepatocellular carcinoma | Li C.-L.; KUN-HUEI YEH ; Liu W.-H.; CHI-LING CHEN ; DING-SHINN CHEN ; PEI-JER CHEN ; Shiou-Hwei Yeh | International Journal of Cancer | 39 | 35 | |
2020 | Elimination of hepatitis B in highly endemic settings: Lessons learned in Taiwan and challenges ahead | CHUN-JEN LIU ; PEI-JER CHEN | Viruses | 25 | 19 | |
2012 | Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia | Afdhal N.H.; Giannini E.G.; Tayyab G.; Mohsin A.; Lee J.-W.; Andriulli A.; Jeffers L.; McHutchison J.; PEI-JER CHEN ; Han K.-H.; Campbell F.; Hyde D.; Brainsky A.; Theodore D. | New England Journal of Medicine | 240 | 215 | |
2014 | Eltrombopag increases platelet numbers in thrombocytopenic patients with hcv infection and cirrhosis, allowing for effective antiviral therapy | Afdhal N.H.; Dusheiko G.M.; Giannini E.G.; PEI-JER CHEN ; Han K.-H.; Mohsin A.; Rodriguez-Torres M.; Rugina S.; Bakulin I.; Lawitz E.; Shiffman M.L.; Tayyab G.-U.-N.; Poordad F.; Kamel Y.M.; Brainsky A.; Geib J.; Vasey S.Y.; Patwardhan R.; Campbell F.M.; Theodore D. | Gastroenterology | 104 | 103 | |
2012 | Emerging hepatitis B virus infection in vaccinated populations: A rising concern? | TUNG-HUNG SU ; PEI-JER CHEN | Emerging Microbes and Infections | 13 | 10 | |
2004 | End-of-treatment virologic response does not predict relapse after lamivudine treatment for chronic hepatitis B | CHUN-JEN LIU ; Huang W.-L.; PEI-JER CHEN ; Lai M.-Y.; JIA-HORNG KAO ; DING-SHINN CHEN | World Journal of Gastroenterology | 14 | 12 | |
2004 | Enhancement of vaccinia vaccine potency by linkage of tumor antigen gene to gene encoding calreticulin | Hsieh C.-J.; Kim T.W.; Hung C.-F.; Juang J.; Moniz M.; Boyd D.A.K.; He L.; PEI-JER CHEN ; CHIEN-HUNG CHEN ; Wu T.-C. | Vaccine | 58 | 56 |